BBI News and Press, Brickell Biotech Inc. From 03/09/20

BOULDER, Colo., March 09, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today an...

TrueCar (NASDAQ: TRUE )  -29%  after guidance disappoints. More news on: TrueCar, Inc., BlueLinx Holdings Inc., EyePoint Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Gainers:  Brickell Biotech (NASDAQ: BBI )  +80% . More news on: Brickell Biotech, Inc., Stamps.com Inc., Adesto Technologies Corporation, Stocks on the move, , Read more ...

Brickell Biotech (NASDAQ: BBI ) +64%  on positive sofpironium bromide data. More news on: Brickell Biotech, Inc., Adesto Technologies Corporation, Stamps.com Inc., Stocks on the move, Read more ...

Are These The Best Penny Stocks To Buy For Under $3 Right Now? Penny stocks are highly speculative and highly volatile. But the one thing all of these cheap stocks have in common is the price. According to the Securities and Exchange Commission’s definition of penny stocks , these ar...

Thinly traded nano cap Brickell Biotech (NASDAQ: BBI ) jumps  49%  premarket on increased volume in reaction to positive results from a Phase 2b clinical trial evaluating topical gel sofpironium bromide in patients with primary hyperhidrosis (excessive sweating, especially in the...

BOULDER, Colo., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today ann...

Gainers: Bellerophon Therapeutics (NASDAQ: BLPH )  +144% . More news on: Bellerophon Therapeutics, Inc., Brickell Biotech, Inc., Wanda Sports Group Company Limited, Stocks on the move, , Read more ...

Thinly traded nano cap Brickell Biotech ( BBI +89.7% ) jumps on a 21x surge in volume in reaction to the settlement of a dispute related to the license agreement for sofpirononium bromide, a compound the company is developing for the potential treatment of hyperhidrosis (excessive sweati...

BOULDER, Colo., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. and its subsidiary (collectively, “Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debi...